Article Results (Showing 1 - 10 of 129) RSS Alert
-
Antegren disappoints in Crohn's disease trials. (Markets: life sciences
BIOGEN INC. has encountered a stumbling block for its investigational drug Antegren (natalizumab), which failed to meet its primary end point in...
Chemical Market Reporter, 08/04/03 by Krause, Carey · More from publication -
Vitamin B3 pricing firms up on robust demand. (Markets: pharmaceuticals & fine chemicals).
THE MARKET FOR nicotinates (vitamin B3) is improving as stronger demand and a more balanced market help to firm up product prices. The industry...
Chemical Market Reporter, 08/04/03 by Krause, Carey · More from publication -
Outlook for Pharma 2Q earnings mixed. (Life Sciences).(pharmaceutical industry earnings)(Industry Overview)
SECOND QUARTER revenue and earnings growth for the large pharmaceutical companies in the US market are expected to be mixed, in part because of...
Chemical Market Reporter, 07/21/03 by Krause, Carey · More from publication -
Gilead Sciences gains FDA approval for Emtriva. (Life Sciences).
GILEAD SCIENCES Inc. has received Food and Drug Administration (FDA) approval for Emtriva (emtricitabine), an antiretroviral. Estimates for...
Chemical Market Reporter, 07/14/03 by Krause, Carey · More from publication -
Genentech gains approval for Xolair. (Life Sciences).(Jointly developed biologic for treating asthma)
GENENTECH INC. has received Food and Drug Administration (FDA) approval for Xolair (omalizumab), a biologic to treat asthma. Xolair may be the...
Chemical Market Reporter, 06/30/03 by Krause, Carey · More from publication -
Novo nordisk plans manufacturing expansion for insulin in Brazil. (Life Science).
NOVO NORDISK A/S will invest $19 million to double production capacity for insulin and expand product packaging in Brazil, solidifying its...
Chemical Market Reporter, 06/23/03 by Krause, Carey · More from publication -
Millennium overhauls operations. (Markets: Life Sciences).(Millennium Pharmaceuticals Inc)
MILLENNIUM Pharmaceuticals Inc. will trim its global work force by 26 percent and consolidate operations under a restructuring plan for...
Chemical Market Reporter, 06/16/03 by Krause, Carey · More from publication -
MSG stabilizes as supply comes into balance. (Markets: Pharmaceuticals & Fine Chemicals).(Monosodium glutamate )
THE MARKET for monosodium glutamate (MSG) is steady after a period of healthy demand in Asia. Producers are operating to capacity and are raising...
Chemical Market Reporter, 06/16/03 by Krause, Carey · More from publication -
Genentech's Avastin poised for BLA. (Life Sciences).(biologics license application)
GENENTECH INC. reported positive Phase III trial data for its anti-angiogenic drug Avastin (bevacizumab) in colorectal cancer, positioning the...
Chemical Market Reporter, 06/09/03 by Krause, Carey · More from publication -
Roche and Maxygen in interferon deal. (Markets: Life Sciences).
ROCHE HOLDING AG inked a $230 million deal with Maxygen Inc. to license its next-generation interferons to treat hepatitis. The deal boosts...
Chemical Market Reporter, 06/02/03 by Krause, Carey · More from publication
